Edesa Biotech, Inc.
EDSA · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $119 | $186 | $183 | $118 |
| Gross Profit | -$119 | -$186 | -$183 | -$118 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,669 | $2,882 | $4,795 | $13,335 |
| G&A Expenses | $4,243 | $4,133 | $4,428 | $5,035 |
| SG&A Expenses | $4,243 | $4,133 | $4,245 | $5,035 |
| Sales & Mktg Exp. | $0 | $0 | -$183 | $0 |
| Other Operating Expenses | -$119 | $0 | $0 | -$780 |
| Operating Expenses | $7,792 | $7,015 | $9,223 | $17,591 |
| Operating Income | -$7,912 | -$7,015 | -$9,223 | -$18,371 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $727 | $845 | $849 | $823 |
| Pre-Tax Income | -$7,185 | -$6,169 | -$8,374 | -$17,548 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | -$7,186 | -$6,170 | -$8,374 | -$17,549 |
| % Margin | – | – | – | – |
| EPS | -1.27 | -1.93 | -2.93 | -8.37 |
| % Growth | 34.2% | 34.1% | 65% | – |
| EPS Diluted | -1.27 | -1.93 | -2.93 | -8.37 |
| Weighted Avg Shares Out | 5,677 | 3,197 | 2,858 | 2,096 |
| Weighted Avg Shares Out Dil | 5,677 | 3,197 | 2,859 | 2,096 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $153 | $290 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $119 | $186 | $183 | $118 |
| EBITDA | -$7,065 | -$5,983 | -$8,190 | -$17,430 |
| % Margin | – | – | – | – |